The CEA and Zionexa have signed an exclusive license agreement for Fludarabine labelled with Fluor 18 ([18F] Fludarabine), an innovative radiopharmaceutical.
ASCO19 Session “Meet the professors: Are we ready for prime time in Molecular Imaging in Breast Cancer?”
We are pleased to announce our participation in ASCO 2019 was a great success, and the keypoints of the ASCO session : “Are we ready for prime time in molecular imaging of breast cancer?".
Discover Peter Webner's Opinion on the Future of Molecular Imaging in DOTmed News.